Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Benefit of Breast Conservation Therapy Confirmed

By HospiMedica staff writers
Posted on 10 Apr 2001
A community study of 626 women who had breast conservation therapy for invasive breast cancer over a 14-year period showed that the recurrence rate was 4% at five years and 8% at 10 years, confirming the findings of national studies. More...
The study was presented at the European Conference on Strategies and Outcomes, in Edinburgh (UK), by doctors from the Radiotherapy Clinics of Georgia (RCOG, Atlanta, USA).

Breast conservation therapy (BCT) allows a woman to keep her breast by removing the tumor (lumpectomy), followed by radiation therapy, which controls microscopic cancer and reduces the recurrence rate by 75%. A second study examined 110 women diagnosed with ductal carcinoma-in-situ, a pre-malignant condition that can progress to invasive cancer. These women were also treated with lumpectomy and radiation therapy over a 14-year period. The breast cancer recurrence rate was 2% at five years and 10% at 10 years.

According to the RCOG, these studies are significant because they represent the largest data set presented by a U.S. community-based treatment program and they reveal the effectiveness of BCT outside the clinical trial and academic institution setting. "The low recurrence rates in these studies document that with careful quality control, excellent results, equivalent to national series, can be achieved in the community setting,” said Dr. Hamilton Williams, a RCOG doctor.

Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Surgical Headlight
IsoTorch
Absorbable Monofilament Mesh
Phasix Mesh
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.